The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, and growing importance of technologies such as machine learning, augmented reality, 5G and Digitalization. In the last three years alone, there have been over 710,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Innovation in medical: intraocular pressure monitoring. Buy the report here.

Smarter leaders trust GlobalData

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

30+ innovations will shape the medical devices industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 155,000 patents, there are 30+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, ultrasonic nebulizers and intra-oral 3D imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Intraocular pressure monitoring, automated diabetes management, and tissue repair implants are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is CPR assistance devices, which is now well established in the industry.

Innovation S-curve for the medical devices industry

Intraocular pressure monitoring is a key innovation area in medical devices

Intraocular pressure (IOP) monitoring refers to the process of measuring the pressure inside the eye for detecting any abnormalities or changes that may be indicative of eye diseases such as glaucoma. Several technologies and methods are used for IOP monitoring, including sensors integrated into contact lenses and ophthalmic lenses, as well as electronic systems that utilize different types of sensors such as optical or strain gauge sensors.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 170+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of intraocular pressure monitoring.

Key players in intraocular pressure monitoring – a disruptive innovation in the medical devices industry

‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.   

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.  

Patent volumes related to intraocular pressure monitoring

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
Johnson & Johnson 323 Unlock Company Profile
Alphabet 320 Unlock Company Profile
Magic Leap 317 Unlock Company Profile
Baxter International 200 Unlock Company Profile
Seed 108 Unlock Company Profile
Sony Group 104 Unlock Company Profile
Visibly 62 Unlock Company Profile
DexCom 61 Unlock Company Profile
Samsung Group 56 Unlock Company Profile
Alcon 56 Unlock Company Profile
Fujifilm 55 Unlock Company Profile
Topcon 55 Unlock Company Profile
Tesseract Health 53 Unlock Company Profile
Vivior 50 Unlock Company Profile
Novartis 48 Unlock Company Profile
LumiThera 47 Unlock Company Profile
EssilorLuxottica 44 Unlock Company Profile
Tobii 40 Unlock Company Profile
Menicon 37 Unlock Company Profile
Cognito Therapeutics 30 Unlock Company Profile
Sejin 30 Unlock Company Profile
Ubiquity Biomedical 28 Unlock Company Profile
Glaukos 26 Unlock Company Profile
Panasonic 25 Unlock Company Profile
Neuro Kinetics 22 Unlock Company Profile
Elbit Systems 22 Unlock Company Profile
Implandata Ophthalmic Products 20 Unlock Company Profile
InteraXon 19 Unlock Company Profile
Neuroptix 19 Unlock Company Profile
NovaSignal 18 Unlock Company Profile
Jins 18 Unlock Company Profile
Oncomfort 17 Unlock Company Profile
Beijing Electronics 16 Unlock Company Profile
Yamaha Motor 16 Unlock Company Profile
20/20 Vision Center 15 Unlock Company Profile
Autonomix Medical 15 Unlock Company Profile
Sharp 14 Unlock Company Profile
Nokia 14 Unlock Company Profile
Apartment Investment and Management 14 Unlock Company Profile
Hennepin Healthcare System 14 Unlock Company Profile
VSP Vision 14 Unlock Company Profile
Alps Alpine 14 Unlock Company Profile
Beijing Zhigu Rui Tuo Tech 14 Unlock Company Profile
International Business Machines 14 Unlock Company Profile
Equinox Ophthalmic 13 Unlock Company Profile
Colgate-Palmolive 12 Unlock Company Profile
Neurable 12 Unlock Company Profile
Bertec 12 Unlock Company Profile
Koninklijke Philips 12 Unlock Company Profile
MindMaze 12 Unlock Company Profile

Source: GlobalData Patent Analytics

Johnson & Johnson and Alphabet are two of the leading patent filers in intraocular pressure monitoring. Some other key patent filers include Magic Leap, Baxter International, and Seed.

In terms of application diversity, Tesseract Health leads the pack, while Cognito Therapeutics and Colgate-Palmolive stood in the second and third positions, respectively. By means of geographic reach, DexCom held the top position, followed by Tesseract Health and Baxter International.

The intraocular pressure monitoring is moving towards continuous monitoring potentially using implantable sensors and non-invasive methods, which will reduce the reliance on traditional methods. Additionally, integration of artificial intelligence and data analytics may enhance early detection and development of highly personalized treatment plan for individuals with glaucoma and other eye conditions. These innovations collectively promise more effective, efficient, and patient-centric eye care in the future.

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.